Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Hoth Therapeutics Inc increased its cash reserves by 44.55%, or 2.86m. Cash Flow from Financing totalled 11.32m or -- of revenues. In addition the company used 8.45m for operations while cash from investing was breakeven.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.74 |
---|---|
Tangible book value per share | 1.74 |
More ▼
Balance sheet in USDView more
Current ratio | 14.62 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼